Furthermore, clinical analyses of the data from The Cancer Genome Atlas (TCGA) and KM plotter databases were performed, and found that TRIM28 and CTTN expression levels were increased in GC and associated with a decreased survival rate (Fig. S1). This evidence concerns the gene CTTN and gastric cancer.